Showing results (161-170 of 419) with videos related to

Sort By:
Pageof 42
Cancer Immunology, Immunotherapy : CII|January 20, 2012
Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancerEmilia Andersson, Lisa Villabona, Kjell Bergfeldt, et al.
Molecular Immunology|May 12, 2009
IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cellsYuqing Shen, Mei Xia, Jianqiong Zhang, et al.
International Journal of Molecular Sciences|March 22, 2018
212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse ModelsBenjamin B Kasten, Patsy G Oliver, Harrison Kim, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2008
Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cellsSonja Verheyden, Soldano Ferrone, Arend Mulder, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 2018
Defective HLA class I antigen processing machinery in cancerLei Cai, Theodoros Michelakos, Teppei Yamada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2016
CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck CancerRaghvendra M Srivastava, Sumita Trivedi, Fernando Concha-Benavente, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stageMarco Vitale, Giuseppe Pelusi, Beatrice Taroni, et al.
Oncogene|May 18, 2005
Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implicationsLizzia Raffaghello, Ignazia Prigione, Paola Bocca, et al.
Stem Cells (Dayton, Ohio)|February 23, 2008
Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigensFabio Morandi, Lizzia Raffaghello, Giovanna Bianchi, et al.
Cancer Immunology, Immunotherapy : CII|July 13, 2005
T-Cell activation by t(9;22) acute lymphoblastic leukemia-derived dendritic-like cells is associated with increased tapasin expressionJonathan A Claus, Michael T Brady, Jaewoo Lee, et al.
Pageof 42